Cullinan Therapeutics Announces Participation in Upcoming Investor Conferences
Cullinan Therapeutics Announces Participation in Upcoming Investor Conferences Cambridge, MA, USA – Cullinan Therapeutics, Inc., a pioneering biopharmaceutical company dedicated to creating modality-agnostic targeted therapies, recently unveiled its intention to partake in several forthcoming investor conferences. The company’s executive team, comprised of Nadim Ahmed, Chief Executive Officer, and Jeffrey Jones, M.D., will represent Cullinan at…